Inhibiting DDR pathways: Artios and the Merck Group team up on oncology drug discovery
DNA damage response (DDR)-focused Artios Pharma has signed a global strategic collaboration with the Merck Group to discover and develop multiple precision cancer drugs.
According...
INOVIO to Develop dMAb COVID Treatments under DARPA Grant
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, announced...
Thermo Fisher Expands Clinical Supply Services in Europe
Thermo Fisher Scientific has expanded its pharma services footprint with two new state-of-the-art facilities in Rheinfelden and Weil am Rhein, Germany. The new sites...
Allergy Alarm Raised On Pfizer-BioNTech COVID-19 Vaccine
02 NHS Workers have reportedly suffered from allergic reactions from the first jab of Pfizer-BioNtech COVID-19 vaccine in the UK
MHRA has issued an advisory...
U.S. FDA confirms Pfizer COVID vaccine safe & effective
The US FDA gives a green signal to Pfizer-BioNTech COVID-19 vaccine as it declairs it to be safe and effective. A US roll-out of...
COVID-19 Vaccine – Has UK created the pressure to rush on other countries?
Has UK's announcement created the pressure on other countries to rush for a COVID-19 vaccine? Are we heading towards another who sends the man...
The UK begins the biggest ever immunization program
There is a history in the making amid the pandemic. You heard it right. The UK has begun the biggest ever immunization program from...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...